<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rifampin-induced <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> has been recognized as an immunological reaction associated with intermittent high-dose therapy, and rarely seen with daily low-dose regimens </plain></SENT>
<SENT sid="1" pm="."><plain>Our patient was a 33-year-old male with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> who was given rifampin 600 mg/d po along with intravenous <z:chebi fb="0" ids="28001">vancomycin</z:chebi> for the treatment of Staphylococcus epidermidis <z:hpo ids='HP_0100584'>endocarditis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>His platelet count dropped from a baseline of 519,000/mm3 to 4000/mm3 after four doses of rifampin </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000967'>Petechiae</z:hpo> were present on the lower extremities without the presence of other <z:mp ids='MP_0001914'>bleeding</z:mp> sites </plain></SENT>
<SENT sid="4" pm="."><plain>Rifampin, low-dose aspirin, and <z:chebi fb="0" ids="4653">dipyridamole</z:chebi> were discontinued </plain></SENT>
<SENT sid="5" pm="."><plain>His platelet count returned to <z:mpath ids='MPATH_458'>normal</z:mpath> nine days after discontinuation of therapy </plain></SENT>
<SENT sid="6" pm="."><plain>With the increasing use of rifampin for the treatment of nontuberculosis <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, clinicians should recognize the possibility of this drug causing such serious immunological reactions as <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, <z:hpo ids='HP_0001919'>acute renal failure</z:hpo>, and shock with daily or intermittent therapy </plain></SENT>
</text></document>